Pattern and clinical phenotype of systemic lupus erythematosus among male patients: Hospital-based study

被引:0
|
作者
Gutbi, Hind Abbas [1 ]
Elagib, Elnour Mohammed [1 ,2 ]
Essa, Mohammed Elmujtba Adam [3 ,4 ]
Ahmed, Noha Ibrahim [1 ,2 ]
Saadelnour, Mohammed Ahmed Idrees [5 ]
机构
[1] Omdurman Mil Hosp, Dept Internal Med & Rheumatol, Omdurman, Sudan
[2] Karary Univ, Fac Med, Dept Med, Omdurman, Sudan
[3] Med & Canc Res Inst, Dept Clin Med, Nyala, Sudan
[4] Alfashir Univ, Fac Med, Al Fashir, Sudan
[5] Univ Kordofan, Fac Med, Al Ubayyid, North Kordofan, Sudan
来源
关键词
constitutional symptoms; males; musculoskeletal; SLE; SEX-DIFFERENCES; RISK; COHORT; MEN;
D O I
10.1002/ctd2.148
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
BackgroundSystemic lupus erythematosus (SLE) is a chronic autoimmune disease of unknown aetiology. SLE is mostly considered a disease of women, though men may also be affected, and this may lead to a delay in diagnosis in men. The result is a greater burden of inflammation and subsequent organ damage over time. This study aims to assess the pattern, clinical phenotype and organ damage in male patients with SLE.MethodsA descriptive cross-sectional study enrolled 30 male SLE patients in Omdurman Military Hospital, Khartoum, Sudan, during the period of December 2019 to May 2020. Data were collected by designated questioner containing demographics, age at diagnosis, clinical manifestations at onset and during the disease course and immunological assays. The data were analyzed by Statistical Package for Social Studies Program.ResultsThe mean age of 35.7 years ranged and the mean age at diagnosis was 32 years, and a third of the patients were found in the age group (30-39 years). The origin distribution showed that 50% of the patients were from central areas, and most of the patients were university graduates, the mean SLE duration was 5 years. Constitutional symptoms were the major manifestation at the onset of SLE in 56.7% of the patients. SLE manifestations during the course of the disease were mainly musculoskeletal manifestations in 87.7% of patients.ConclusionThe mean duration of the disease is 5 years, and the mean age of the patients is in the middle of their thirties, the constitutional symptoms were the major manifestation and musculoskeletal manifestations came second to that and almost all of them have positive antinuclear antibodies and anti-dsDNA. In the antibodies profile of male SLE patients in Omdurman Military Hospital (N = 30), all the patients have positive antinuclear antibodies, more than half have positive anti-DNA and only 3% of them have proliferating cell nuclear antigen. image
引用
收藏
页数:7
相关论文
共 50 条
  • [31] Subclinical Atherosclerosis and Endothelial Dysfunction in Cases of Systemic Lupus Erythematosus: A Hospital-Based Case-Control Study
    Biswas, Tapobrata
    Tarenia, Silima
    Bera, Sudipta
    Naiya, Sourav
    Acharya, Sourya
    Shukla, Samarth
    Kumar, Sunil
    Pantbalekundri, Nikhil
    Giri, Anamika G.
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2024, 16 (08)
  • [32] INFLUENCE OF AGE ON CLINICAL PATTERN OF SYSTEMIC LUPUS ERYTHEMATOSUS
    UROWITZ, MB
    STEVENS, MB
    SHULMAN, LE
    ARTHRITIS AND RHEUMATISM, 1967, 10 (03): : 319 - &
  • [33] Acetylation genotype and phenotype in patients with systemic lupus erythematosus
    Rychlik-Sych, M
    Skretkowicz, J
    Gawronska-Szklarz, B
    Górnik, W
    Sysa-Jedrzejowska, A
    Skretkowicz-Szarmach, K
    PHARMACOLOGICAL REPORTS, 2006, 58 (01) : 22 - 29
  • [34] Exploring the experience of male patients with systemic lupus erythematosus - A qualitative study
    Ferenkeh-Koroma, A. H.
    Isenberg, D. A.
    Rahman, A.
    ANNALS OF THE RHEUMATIC DISEASES, 2007, 66 : 84 - 85
  • [35] Exploring the experience of male patients with systemic lupus erythematosus a qualitative study
    Ferenkeh-Koroma, A. H.
    Isenberg, D. A.
    Rahman, A.
    ANNALS OF THE RHEUMATIC DISEASES, 2007, 66 : 637 - 638
  • [36] Prednisolone dose during treatment of tuberculosis might be a risk factor for mortality in patients with systemic lupus erythematosus: a hospital-based cohort study
    Cheng, C. F.
    Huang, Y. M.
    Lu, C. H.
    Hsieh, S. C.
    Li, K. J.
    LUPUS, 2019, 28 (14) : 1699 - 1704
  • [37] Association of discoid lupus with other clinical manifestations among patients with systemic lupus erythematosus
    Merola, J. F.
    Prystowsky, S. D.
    Iversen, C.
    Gomez-Puerta, J. A.
    Norton, T.
    Tsao, P.
    Massarotti, E.
    Schur, P.
    Bermas, B.
    Costenbader, K. H.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2013, 133 (06) : 1694 - 1694
  • [38] CLINICAL MANIFESTATIONS OF SYSTEMIC LUPUS ERYTHEMATOSUS - STUDY OF 45 PATIENTS
    BENNETT, JC
    CLAYBROOK, J
    KINSEY, H
    HOLLEY, HL
    JOURNAL OF CHRONIC DISEASES, 1961, 13 (05): : 411 - +
  • [39] Association of Discoid Lupus with Other Clinical Manifestations Among Patients with Systemic Lupus Erythematosus
    Merola, Joseph F.
    Iversen, Christina
    Gomez-Puerta, Jose A.
    Norton, Tabatha
    Tsao, Hsun
    Schur, Peter H.
    Massarotti, Elena M.
    Bermas, Bonnie L.
    Costenbader, Karen H.
    ARTHRITIS AND RHEUMATISM, 2012, 64 (10): : S264 - S264
  • [40] Clinical and laboratory pattern of patients with systemic lupus erythematosus seropositive for rheumatoid factor
    Iaremenko, Oleg
    Protsenko, Galyna
    Dubas, Vitalii
    Koliadenko, Daria
    REUMATOLOGIA, 2024, 62 (04): : 226 - 234